Optimization of antiproliferative activity of substituted phenyl 4-(2-oxoimidazolidin-1-yl) benzenesulfonates: QSAR and CoMFA analyses
- 1 September 2015
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 77, 230-237
Abstract
No abstract availableKeywords
Funding Information
- Deanship of Scientific Research (RG-1435-083)
This publication has 11 references indexed in Scilit:
- Optimization of Antimalarial Activity of Synthetic Prodiginines: QSAR, GUSAR, and CoMFA analysesChemical Biology & Drug Design, 2013
- Rational drug design for identifying novel multi-target inhibitors for hepatocellular carcinoma.Anti-Cancer Agents in Medicinal Chemistry, 2012
- Integrating GUSAR and QSAR analyses for antimalarial activity of synthetic prodiginines against multi drug resistant strainMedicinal Chemistry Research, 2012
- Synthesis, biological evaluation, and structure–activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitorsOrganic & Biomolecular Chemistry, 2012
- Understanding the Basis of Drug Resistance of the Mutants of αβ-Tubulin Dimer via Molecular Dynamics SimulationsPLOS ONE, 2012
- CoMSIA and POM analyses of anti-malarial activity of synthetic prodigininesBioorganic & Medicinal Chemistry Letters, 2012
- k-NN, quantum mechanical and field similarity based analysis of xanthone derivatives as α-glucosidase inhibitorsMedicinal Chemistry Research, 2012
- Substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure-activity relationshipsEuropean Journal of Medicinal Chemistry, 2011
- Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathwayBioorganic & Medicinal Chemistry, 2011
- QSAR and CoMFA studies of biphenyl analogs of the anti-tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo [2,1-b][1,3]oxazine (PA-824)Medicinal Chemistry Research, 2011